Determination of the Absorption, Metabolism, Excretion and Absolute Bioavailability of SCH 900777 in Healthy, Adult, Male Volunteers (P-05905).

Determination of the Absorption, Metabolism, Excretion and Absolute Bioavailability of SCH 900777 in Healthy, Adult, Male Volunteers (P-05905). - 14 C AME Study with SCH 900777 (Org 26576)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON34835

Enrollment

Registered

2010-01-08

Start date

2010-02-14

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depression

Interventions

Study Medication Active substance: SCH 900777 and [14C]-SCH 900777

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: male 18-55 years BMI_ 19-30 kg/m2 non smoker or light smoker

Exclusion criteria

Exclusion criteria: Suffering from: hepatitis B, cancer or HIV/AIDS. In case of participation in another drug study within 60 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 1.5 liters of blood in the 10 months preceding the start of this study.

Design outcomes

Primary

Measure	Time frame
Criteria for evaluation: Pharmacokinetics Radiokinetics Safety Statistical Methods: Pharmakinetics parameters : descriptive statistics Safety parameters : descriptive statistics	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)